Moody Aldrich Partners LLC Karuna Therapeutics, Inc. Transaction History

Moody Aldrich Partners LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$161.01 - $317.85 $118,986 - $234,891	739 Added 33.41%	2,951 $934,000
Q3 2023 Nov 07, 2023	SELL	$164.66 - $218.08 $1.19 Million - $1.57 Million	-7,215 Reduced 76.54%	2,212 $374,000
Q2 2023 Jul 28, 2023	SELL	$176.32 - $240.22 $613,593 - $835,965	-3,480 Reduced 26.96%	9,427 $2.04 Million
Q1 2023 Apr 27, 2023	SELL	$161.33 - $204.36 $830,526 - $1.05 Million	-5,148 Reduced 28.51%	12,907 $2.34 Million
Q4 2022 Jan 23, 2023	BUY	$191.53 - $236.82 $539,348 - $666,885	2,816 Added 18.48%	18,055 $0
Q3 2022 Oct 18, 2022	SELL	$123.79 - $277.42 $579,460 - $1.3 Million	-4,681 Reduced 23.5%	15,239 $3.43 Million
Q2 2022 Jul 18, 2022	BUY	$93.97 - $143.33 $1.87 Million - $2.86 Million	19,920 New	19,920 $2.52 Million
Q2 2021 Aug 04, 2021	SELL	$107.45 - $135.95 $1.07 Million - $1.35 Million	-9,929 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$95.46 - $133.08 $904,769 - $1.26 Million	-9,478 Reduced 48.84%	9,929 $1.19 Million
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $869,884 - $1.26 Million	-11,563 Reduced 37.34%	19,407 $1.97 Million
Q3 2020 Nov 12, 2020	BUY	$71.31 - $109.74 $47,920 - $73,745	672 Added 2.22%	30,970 $2.4 Million
Q2 2020 Jul 30, 2020	BUY	$62.14 - $117.21 $276,771 - $522,053	4,454 Added 17.23%	30,298 $3.38 Million
Q1 2020 May 07, 2020	BUY	$60.41 - $115.92 $2,416 - $4,636	40 Added 0.16%	25,844 $1.86 Million
Q4 2019 Feb 07, 2020	BUY	$11.44 - $123.99 $295,197 - $3.2 Million	25,804 New	25,804 $1.94 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.